TumstatinAlternative Names: Tumor-statin; Tumour-statin
Latest Information Update: 12 Dec 2007
At a glance
- Originator Beth Israel Deaconess Medical Center
- Class Amino acids; Antineoplastics
- Mechanism of Action Angiogenesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Solid tumours